Pàgina 1 des de 47 resultats
BACKGROUND OF THE INVENTION
The use of radiometal-labeled complexes and biomolecules as diagnostic agents is a relatively new area of medicinal chemistry. Research into .sup.99mTc radiopharmaceutical was the beginning of the study of coordinate chemistry as it related to diagnostic imaging. Since
FIELD OF THE INVENTION
The present invention relates to the use of chlorine dioxide compositions for treating cancerous tumors. The present invention relates to compositions and methods for treating cancerous tumors, including naive, metastatic and recurrent cancers. The compositions comprise
FIELD OF THE INVENTION
The present invention relates to the use of chlorine dioxide compositions for treating cancerous tumors. The present invention relates to compositions and methods for treating cancerous tumors, including naive, metastatic and recurrent cancers. The compositions comprise
FIELD OF INVENTION
The present invention relates to compounds of the following formula:
##STR00002## wherein X is fluorine or chlorine; Y is oxygen, sulfur, or an imino group; R is an amino, hydroxyl, sulfonamide, or carboxamide group or an N-monomethyl or N-dimethyl analog thereof; m is an integer
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a national stage filing under section 371 of International Application No. PCT/EP2016/053172, filed on Feb. 15, 2016, and published on Aug. 25, 2016 as WO 2016/131776, which claims priority to Great Britain Application No. 1502567.9, filed
TECHNICAL FIELD
This invention is a method of treating cancer, both carcinomas and sarcomas, and viral infections, in particular HIV through the administration of a pharmaceutical composition containing a benzimidazole derivative. The composition is also claimed.
BACKGROUND OF THE INVENTION
Cancers
TECHNICAL FIELD
This invention is a method of treating cancer, both carcinomas and sarcomas, and viral infections, in particular HIV through the administration of a pharmaceutical composition containing a benzimidazole derivative. The composition is also claimed.
BACKGROUND OF THE INVENTION
Cancers
TECHNICAL FIELD
This invention is a method of treating cancer, both carcinomas and sarcomas, and viral infections, in particular HIV through the administration of a pharmaceutical composition containing a benzimidazole derivative. The composition is also claimed.
BACKGROUND OF THE INVENTION
Cancers
BACKGROUND OF THE DISCLOSURE
This invention relates to a method of treating meningeal leukemia and CNS lymphoma and neoplasms in the brain in man and pharmaceutical preparations suitable for such use.
More effective antileukemic therapy and consequent longer survival has the unfortunate consort of
This application is a National Stage application of PCT/FR2005/000084, filed Jan. 14, 2005, which claims priority from French patent application FR 0400298, filed Jan. 14, 2004. The entire contents of each of the aforementioned applications are incorporated herein by reference.
The subject of the
CROSS-REFERENCES TO RELATED APPLICATION
This patent application claims the benefit of priority from Korean Patent Application No. 10-2012-0049643, filed on May 10, 2012, the contents of which are incorporated herein by reference.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present
TECHNICAL FIELD
The present invention relates to methods of using one or more benzimidazole compounds and its pharmaceutically acceptable derivatives to treat and prevent cancer in both both human and warm blooded animals. In particular, this invention relates to benzimidazole and its derivatives in
The present invention relates to the use of substituted acryloyl distamycin derivatives, in particular to the use of .alpha.-bromo- and .alpha.-chloroacryloyl distamycin derivatives, in the treatment of tumors associated with high levels of glutathione and/or glutathione-S-transferases family.
More
TECHNICAL FIELD
The present invention relates to methods of using one or more benzimidazole compounds and its pharmaceutically acceptable derivatives to treat and prevent cancer in both human and warm blooded animals. In particular, this invention relates to benzimidazole and its derivatives in
BACKGROUND OF THE INVENTION
The present invention relates to DC-89 derivatives. The compounds have an excellent anti-tumor activity and are useful as anti-tumor agents.
As compounds structurally similar to the DC-89 derivatives of the present invention, those represented by the following structure